Synmosa Biopharma Corporation
4114
Rank in Stocks
#12574
Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates... Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates as a dedicated specialty pharmaceutical enterprise. The company manages the entire lifecycle of pharmaceutical and healthcare products, from research and development to manufacturing, marketing, and distribution, primarily serving the Taiwanese market under its proprietary Synmosa brand. Its diverse product portfolio addresses key therapeutic categories, including cardiovascular health, respiratory conditions, urology, sex hormone treatments, and oncology. These offerings are available in various formats such as effervescent tablets, granules, nasal sprays, metered-dose inhalers, hormonal preparations, and other specialized forms. Beyond its proprietary products, Synmosa also extends its expertise through contract manufacturing services. The company maintains a significant international presence, exporting its goods to numerous countries including South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua.
Share Price
$0.84746795
Last synced: 2026-11-10
Market Cap
$458.56M
Change (1 day)
-0.18%
Change (1 year)
-13.81%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Synmosa Biopharma Corporation (4114)
Category
Healthcare
EPS for Synmosa Biopharma Corporation (4114)
EPS as of June 2026 TTM: $0.05
According to Synmosa Biopharma Corporation's latest financial reports, its current EPS (TTM) is $0.05. At the end of 2025 the company had an EPS of $0.05, an increase over its 2024 EPS of $0.04.
EPS history for Synmosa Biopharma Corporation from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.05 | -2.40% |
| 2025 | $0.05 | 18.08% |
| 2024 | $0.04 | -5.88% |
| 2023 | $0.05 | -35.15% |
| 2022 | $0.07 | 142.24% |
| 2021 | $0.03 | -57.20% |
| 2020 | $0.07 | 1,546.51% |
| 2019 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 13,222.54% |
DE
|
|
| $6.08 | 12,354.10% |
DE
|
|
| $1.55 | 3,077.46% |
JP
|
|
| $3.66 | 7,400.00% |
CH
|
|
| $0.45 | 822.13% |
IL
|
Questions about Synmosa Biopharma Corporation's earnings per share (EPS)
What is Synmosa Biopharma Corporation's earnings per share (EPS)?
Synmosa Biopharma Corporation's earnings per share (EPS) over the last twelve months is $0.05, as of Jun 2026.
What was Synmosa Biopharma Corporation's earnings per share (EPS) in 2025?
In 2025, Synmosa Biopharma Corporation's earnings per share (EPS) was $0.05, 25.00% more than in 2024 ($0.04).
How has Synmosa Biopharma Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Synmosa Biopharma Corporation's earnings per share (EPS) went from $0.07 to $0.05, an average decline of 6.51% a year.
How does Synmosa Biopharma Corporation's earnings per share (EPS) compare with similar companies?
Synmosa Biopharma Corporation's earnings per share (EPS) ($0.05) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.